Contributions of ScopeSeverin
User contributions·23 logged edits·page 1 of 1
Contributions by ScopeSeverin, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 855 edits includes activity predating the current log.
- 10:35, 29 Jun 2026 (diff | hist) Talk:Sharps disposal 1,096 +215 /* Colour-coding table is England-specific and presented as general */ reply
- 11:05, 24 Apr 2026 (diff | hist) Talk:Lyophilisation 1,507 +171 /* Section on unregulated ambient shipping — is it in scope here? */ reply
- 15:30, 21 Apr 2026 (diff | hist) Talk:Lyophilisation 1,085 +310 /* Section on unregulated ambient shipping — is it in scope here? */ new section
- 11:34, 17 Apr 2026 (diff | hist) Talk:Beyond-use date 1,581 +163 /* Community dating practice: describe or omit? */ reply
- 10:52, 14 Apr 2026 (diff | hist) Talk:Beyond-use date 948 +337 /* Community dating practice: describe or omit? */ new section
- 10:27, 5 Apr 2026 (diff | hist) Talk:Cold chain 2,003 +231 /* RfC: should this article cover consumer shipping practice? */ reply
- 11:38, 2 Apr 2026 (diff | hist) Talk:Cold chain 1,159 +306 /* RfC: should this article cover consumer shipping practice? */ reply
- 09:12, 14 Feb 2026 (diff | hist) Talk:Temperature excursion 1,940 +217 /* Is a community-reported stability observation usable evidence at all? */ reply
- 15:47, 24 Sep 2025 (diff | hist) Peptide stability table 5,688 ±0 m de-orphan
- 13:50, 3 Sep 2025 (diff | hist) Flourishglobal Peptide Biotech 8,671 +783 m label community tally as self-reported
- 22:24, 10 May 2025 (diff | hist) Shanghai Wibson Biotechnology 6,586 +339 m move table to the section it supports
- 09:33, 23 Apr 2025 (diff | hist) Talk:ChinaPeptides 822 +195 /* Which name should the article title use? */ reply
- 09:51, 28 Mar 2025 (diff | hist) Talk:GL Biochem (Shanghai) 959 +220 /* Upstream versus retail: is this the same kind of article? */ reply
- 13:19, 2 Feb 2025 (diff | hist) Talk:Shanghai Wibson Biotechnology 611 +286 /* Notability with a five-year history and no independent coverage */ reply
- 18:03, 17 Jan 2025 (diff | hist) Nantong Guangyuan Chemical 6,634 ±0 m fix hyphenation per PP:MOS
- 10:26, 11 Jan 2025 (diff | hist) Talk:Sangon Biotech 1,033 +75 /* Scope: is this a peptide supplier article at all? */ reply
- 11:04, 8 Jan 2025 (diff | hist) Talk:Sangon Biotech 400 +295 /* Scope: is this a peptide supplier article at all? */ new section
- 12:15, 21 Nov 2024 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 611 +269 /* Notability and the registered business scope */ reply
- 03:04, 20 Oct 2024 (diff | hist) Insulin syringe unit conversion 1,302 ±0 m label community tally as self-reported
- 05:05, 12 Oct 2024 (diff | hist) Reconstitution calculator 1,663 ±0 split section
- 10:28, 10 Oct 2024 (diff | hist) Talk:Nantong Guangyuan Chemical 1,033 +129 /* Multiple trading names: which is the title? */ reply
- 05:59, 7 Sep 2024 (diff | hist) Reconstitution calculator 1,365 ±0 consistent en dashes in ranges
- 11:31, 15 Aug 2024 (diff | hist) Talk:WuXi TIDES 1,033 +215 /* Notability, and the name problem */ reply